“Evaluation of CD4+, CD39+, FOXP3+Tregulatory cells in Iraqi Alopecia areata patients by ELISA”, Journal of Pharmaceutical Negative Results, vol. 13, pp. 247–250, Oct. 2022, doi: 10.47750/pnr.2022.13.S05.32.